Dozens of children may have died in The Gambia from contaminated cough and cold syrups.
Now the Indian manufacturer is to stop production.
This was ordered by the regional government in the Indian state of Haryana, where Maiden Pharmaceuticals Limited is based, as the Indian news agency ANI reported on Wednesday.
Accordingly, the local health minister Anil Vij said that various deficiencies were found during an inspection at the production facility.
In addition, cough syrup samples are currently being evaluated in a laboratory.
According to the authorities and the company, the drugs concerned have only been delivered to Gambia.
Blow for the "Pharmacy of the World"
The World Health Organization (WHO) warned about the funds last week.
According to the WHO, the cough and cold syrups sold in Gambia are suspected of triggering acute kidney failure and causing the deaths of more than 60 children.
The Gambian health authorities also called for the suspected juices to no longer be prescribed.
According to them, the children affected by kidney failure were under five years old.
According to the Gambian police, 50,000 bottles of the suspected contaminated drugs were brought into the country.
A large part of them, around 41,500 products, were confiscated by the health authorities. India is considered the "pharmacy of the world" and produces many medicines inexpensively, especially for poorer countries.